WAT
Waters Corporation
NYSE · Healthcare · Medical - Diagnostics & Research · US
$409.38
−1.01%Forward multiples
Based on analyst estimates
- P/E forward
- 26.22x
- P/E 2026E
- 28.21x
- P/E 2027E
- 24.91x
- P/E 2028E
- 22.36x
- P/S forward
- 5.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- 101.84x
- PEG TTM
- 0.35x
- Price / book
- 2.65x
- Price / sales
- 8.66x
- Price / cash flow
- 73.15x
Enterprise value
- Enterprise value
- $44.9B
- EV / sales
- 9.68x
- EV / EBITDA
- 50.16x
- EV / EBIT
- 121.55x
- Market cap
- $40.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026